Vanda Pharmaceuticals Announces Participation at May 2026 Investor Conferences

Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) announced its participation in three investor conferences in May 2026. These include the Bank of America Securities Global Health Care Conference, the HCW 4th Annual BioConnect Investor Conference, and the B. Riley Securities 26th Annual Investor Conference. A fireside chat at the HCW conference will be broadcast live on Vanda’s corporate website.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin